HT-6153

N/A

Report date: 2023/12/22 14:17:51
NME

Base Information

Drug NameHT-6153
Drug Alias NameHT-6153
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerine/threonine-protein kinase Nek7 inhibitors
TargetsSerine/threonine-protein kinase Nek7
Therapy Area/IndicationsIntervertebral disc disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesHalia Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesHalia Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsIntervertebral disc disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A